Description
A product of purine and uric acid metabolism; Urinary levels of allantoin are increased in APP/tau mice prior to the onset of Alzheimer’s disease symptoms but not during the early/middle stage of the disease, indicating a potential use as a biomarker for predicting Alzheimer’s disease onset; increased urinary levels are a potential biomarker for oxidative stress status in humans
Formal name: N-(2,5-dioxo-4-imidazolidinyl)-urea
Synonyms: (±)-Allantoin|5-Ureidohydantoin|NSC 7606|SD 101
Molecular weight: 158.1
CAS: 97-59-6
Purity: ≥95%
Formulation: A crystalline solid